Liraglutide in Spinal Fluid
Not Applicable
Completed
- Conditions
- Liraglutide Blood-brain Transfer
- Registration Number
- NCT02104037
- Lead Sponsor
- Mikkel Christensen
- Brief Summary
The purpose of this study is to investigate transfer of liraglutide from blood to cerebrospinal fluid.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 8
Inclusion Criteria
Type 2 diabetes treated with liraglutide 1.8 mg for 1 month and 5% weight loss
Exclusion Criteria
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SINGLE_GROUP
- Primary Outcome Measures
Name Time Method cerebrospinal fluid concentration of liraglutide time 60 minutes
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Diabetes Research Division, Department of Medicine
🇩🇰Hellerup, Denmark
Diabetes Research Division, Department of Medicine🇩🇰Hellerup, Denmark